Streetbeat News

Price Targets

ALGT

Morgan Stanley analyst Ravi Shanker has maintained an Equal-Weight rating on Allegiant Travel (NASDAQ:ALGT) and lowered the price target from $100 to $95.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:29 pm

VTYX

Stifel analyst Alex Thompson has downgraded Ventyx Biosciences (NASDAQ:VTYX) from Buy to Hold and set a price target of $6.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:27 pm

ADTN

Rosenblatt analyst Mike Genovese has downgraded Adtran (NASDAQ:ADTN) from Buy to Neutral and lowered the price target from $11 to $7.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:25 pm

CHRS

HC Wainwright & Co. analyst Douglas Tsao maintains a 'Buy' rating on Coherus BioSciences (NASDAQ:CHRS) but lowers the price target from $20 to $13.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:22 pm

ZNTL

HC Wainwright & Co. analyst Andrew Fein maintains a 'Buy' rating on Zentalis Pharma (NASDAQ:ZNTL), but has lowered the price target from $55 to $46.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:18 pm

NWE

Ladenburg Thalmann analyst Paul Fremont has downgraded NorthWestern Energy Group (NASDAQ:NWE) from Buy to Neutral and set a price target of $51.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:17 pm

VRTX

HC Wainwright & Co. analyst Andrew Fein maintains a 'Buy' rating on Vertex Pharmaceuticals (NASDAQ:VRTX) and raises the price target from $380 to $390.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:15 pm

MRTX

Leerink Partners analyst Andrew Berens has downgraded Mirati Therapeutics (NASDAQ:MRTX) from Outperform to Market Perform and lowered the price target from $78 to $58.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 1:12 pm

KW

B of A Securities has downgraded Kennedy-Wilson Holdings (NYSE:KW) from Neutral to Underperform and lowered the price target from $18 to $6.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:59 pm

SONO

B of A Securities analyst John Babcock has downgraded Sonos (NASDAQ:SONO) from Buy to Neutral and lowered the price target from $20 to $12.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:56 pm